Skip to Main Content

Scott Huntington, MD, MPH, MSc

Hematologic Oncology, Leukemia & Lymphoma, Hematology
Telehealth is available
Learn more about telehealth
Patient type treated
Adult
Accepting new patients
Yes
Referral required
From patients or physicians
Board Certified in
Internal Medicine, Medical Oncology , and Hematology (Internal Medicine)

Biography

Scott Huntington, MD, MPH is a physician and researcher at Yale School of Medicine specializing in the care of patients with lymphoma and chronic lymphocytic leukemia.

Dr. Huntington diagnoses and treats common lymphoma disorders, including chronic lymphocytic leukemia (CLL), Hodgkin lymphoma, and mantle cell lymphoma, in addition to rare types such as Hairy cell leukemia, primary mediastinal B-cell lymphoma (PMBCL) and gray zone lymphoma. Dr. Huntington also has leadership roles as the Chief Quality Officer for Smilow Cancer Center and the Firm Chief for the inpatient blood cancer service.

Dr. Huntington is an active researcher at Yale’s Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, where he leads research focused on improving the delivery of complex cancer treatment and improving patient outcomes. He is also an active clinical trial investigator, evaluating novel cancer therapeutics in individuals with CLL, Hodgkin lymphoma, and B cell non-Hodgkin lymphomas.

A recipient of the Conquer Cancer Foundation of ASCO Merit Award, Armstrong Founders Award, and 40 under 40 in Cancer, Dr. Huntington is an associate professor of internal medicine at Yale University School of Medicine.

Titles

  • Associate Professor of Internal Medicine (Hematology)
  • Chief Quality Officer, Smilow Cancer Hospital and Yale Cancer Center
  • Chief, Inpatient Cancer Medicine

Education & Training

  • Fellowship
    University of Pennsylvania (2015)
  • MSc
    University of Pennsylvania, Health Policy (2015)
  • Residency
    Vanderbilt University (2012)
  • MPH
    Mount Sinai School of Medicine (2009)
  • MD
    Mount Sinai School of Medicine (2009)

Additional Information

Locations
Smilow Cancer Hospital at Yale New Haven
35 Park Street
New Haven, CT 06511

Biography

Scott Huntington, MD, MPH is a physician and researcher at Yale School of Medicine specializing in the care of patients with lymphoma and chronic lymphocytic leukemia.

Dr. Huntington diagnoses and treats common lymphoma disorders, including chronic lymphocytic leukemia (CLL), Hodgkin lymphoma, and mantle cell lymphoma, in addition to rare types such as Hairy cell leukemia, primary mediastinal B-cell lymphoma (PMBCL) and gray zone lymphoma. Dr. Huntington also has leadership roles as the Chief Quality Officer for Smilow Cancer Center and the Firm Chief for the inpatient blood cancer service.

Dr. Huntington is an active researcher at Yale’s Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, where he leads research focused on improving the delivery of complex cancer treatment and improving patient outcomes. He is also an active clinical trial investigator, evaluating novel cancer therapeutics in individuals with CLL, Hodgkin lymphoma, and B cell non-Hodgkin lymphomas.

A recipient of the Conquer Cancer Foundation of ASCO Merit Award, Armstrong Founders Award, and 40 under 40 in Cancer, Dr. Huntington is an associate professor of internal medicine at Yale University School of Medicine.

Titles

  • Associate Professor of Internal Medicine (Hematology)
  • Chief Quality Officer, Smilow Cancer Hospital and Yale Cancer Center
  • Chief, Inpatient Cancer Medicine

Education & Training

  • Fellowship
    University of Pennsylvania (2015)
  • MSc
    University of Pennsylvania, Health Policy (2015)
  • Residency
    Vanderbilt University (2012)
  • MPH
    Mount Sinai School of Medicine (2009)
  • MD
    Mount Sinai School of Medicine (2009)

Additional Information

Locations
Smilow Cancer Hospital at Yale New Haven
35 Park Street
New Haven, CT 06511
Smilow Cancer Hospital at Yale New Haven
35 Park Street
New Haven, CT 06511